My Blue Dots – Page 33

MyBlueDots

Telehealth and Telemedicine Research, 2020-2024 & 2025-2030 with Analyst Recommendations – Integration of Wearable Devices and the IoT / Develop Strategies for Expanding Adoption in Emerging Markets – ResearchAndMarkets.com

MyBlueDots4 weeks ago01 mins

DUBLIN–(BUSINESS WIRE)–The “Telehealth and Telemedicine Market (2024 Edition): Analysis By Component (Software, Services, and Hardware), By Mode of Delivery, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Telehealth and Telemedicine market showcased growth at a CAGR of 24.02% during 2020-2023. The market was valued at USD 113.28 Billion in 2023 which is expected to reach USD 462.19 Billion

Red light linked to lowered risk of blood clots

MyBlueDots4 weeks ago01 mins

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.

Medicare rules may reduce prescription steering

MyBlueDots4 weeks ago01 mins

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, these pharmacies appear less used in Medicare than in other market segments. These PBMs are part of integrated health care conglomerates that own insurance companies and pharmacies, which may create conflicts of interest.

MyBlueDots

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

MyBlueDots4 weeks ago01 mins

BERLIN–(BUSINESS WIRE)–Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body weight which represents a gadolinium dose reduction of 60 percent compared to the macrocyclic GBCAs dosed at 0.

What does it mean to have a ‘mental health crisis’?

MyBlueDots4 weeks ago01 mins

When we think of a mental health crisis, we often imagine an unpredictable and intense manifestation of a negative mental state.

New study suggests hearing loss may be early indicator of Parkinson’s

MyBlueDots4 weeks ago01 mins

There may be a link between hearing impairment and an increased risk of developing Parkinson’s according to research led by Lancaster University.

New drug for prostate cancer patients in clinical trials

MyBlueDots4 weeks ago01 mins

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical Cancer Research.

Research shows the complexity of childhood trauma

MyBlueDots4 weeks ago01 mins

“Kids are resilient” is a refrain often repeated as a source of comfort after an incident in childhood. But what if it just isn’t aways true?

New AI-powered app brings infant jaundice screening home for Asian parents

MyBlueDots4 weeks ago01 mins

For the first two to three weeks of their lives, infants have to undergo screening for neonatal jaundice (NNJ). It typically involves frequent clinic visits, which is not only inconvenient, but vulnerable infants could potentially be exposed to airborne diseases.

Why new precision oncology treatments benefit patients of some ancestries more than others

MyBlueDots4 weeks ago01 mins

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth.

Useful _Links

Generally, things really do seem better in the morning, large study suggests

GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds

Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

New insights into liver maturation and specialization could advance regenerative medicine

Research shows positive changes in opioid prescribing, but trend among young people a cause for concern

Telehealth and Telemedicine Research, 2020-2024 & 2025-2030 with Analyst Recommendations – Integration of Wearable Devices and the IoT / Develop Strategies for Expanding Adoption in Emerging Markets – ResearchAndMarkets.com

Red light linked to lowered risk of blood clots

Medicare rules may reduce prescription steering

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

What does it mean to have a ‘mental health crisis’?

New study suggests hearing loss may be early indicator of Parkinson’s

New drug for prostate cancer patients in clinical trials

Research shows the complexity of childhood trauma

New AI-powered app brings infant jaundice screening home for Asian parents

Why new precision oncology treatments benefit patients of some ancestries more than others

World News

Useful Links

Health

Business

Entertainment

About Us